NCT05016284View on ClinicalTrials.gov

Comparison of JW-100 and EUCRISA for the Treatment of Atopic Dermatitis

PHASE3WithdrawnINTERVENTIONAL
0
Timeline

Start Date

November 24, 2022

Primary Completion Date

December 15, 2022

Study Completion Date

December 15, 2022

Conditions
Atopic Dermatitis
Interventions
OTHER

JW-100

Cosmetic CBD cream (JW-100)

DRUG

Eucrisa

Topical EUCRISA®, Pfizer

Trial Locations (1)

69020030

Centro Universitário Nilton Lins, Manaus

Sponsors
All Listed Sponsors
collaborator

Jupiter Wellness, Inc.

UNKNOWN

lead

Applied Biology, Inc.

INDUSTRY